Advances in the pathogenesis of cardiorenal syndrome type 3

Area of Science:

• Nephrology
• Cardiology
• Pathophysiology

Background:

• Cardiorenal Syndrome (CRS) type 3 describes acute kidney injury (AKI) leading to acute cardiac dysfunction.
• The underlying pathophysiologic mechanisms of CRS type 3 are not fully understood.
• AKI can directly and indirectly precipitate cardiac events, influenced by AKI severity and duration.

Purpose of the Study:

• To review and elucidate the multifactorial pathogenesis of Cardiorenal Syndrome type 3.
• To consolidate current understanding of the links between acute kidney injury and acute cardiac dysfunction.

Main Methods:

• Literature review focusing on experimental data and clinical observations.
• Analysis of factors contributing to cardiac dysfunction secondary to AKI.
• Synthesis of information on immune activation, inflammation, oxidative stress, and apoptosis in AKI.

Main Results:

• Experimental data indicate that AKI-induced immune system activation, inflammatory mediator release, oxidative stress, and apoptosis contribute to cardiac dysfunction.
• Metabolic derangements common in AKI, including fluid/electrolyte imbalance, metabolic acidosis, and uremia, can impair cardiac function.
• Multiple interconnected factors are implicated in the pathogenesis of CRS type 3.

Conclusions:

• Acute kidney injury triggers a cascade of events that can lead to acute cardiac injury.
• Understanding these mechanisms is crucial for developing targeted therapies for Cardiorenal Syndrome type 3.
• Further research is needed to fully unravel the complex interplay between the kidneys and heart in CRS type 3.